ALEXANDRIA, Va., Jan. 28 -- United States Patent no. 12,534,540, issued on Jan. 27, was assigned to Clemson University Research Foundation (Clemson, S.C.).
"CYP1A1-targeted monoclonal antibody with reactivity across vertebrate taxa" was invented by Charles David Rice (Clemson, S.C.).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention is directed to a monoclonal antibody or an antigen binding fragment thereof targeting the expression and function of CYP1A1 with cross reactivity across the vertebrate taxa. This invention is also directed to nucleic acid molecules, vectors, host cells and compositions comprising the same, as well as methods for use of the same and for producing the same."
The patent w...